Shareholding for the Period Ended March 31, 2018
Novartis India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click here16-04-2018
16-04-2018
Certificate Pursuant To Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements), Regulations 2015 For The Period Ended March 31, 2018
Pursuant to Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we enclose herewith a Certificate from a Practicing Company Secretary confirming that all certificates have been issued within thirty days of the date of lodgement for transfer, sub-division, consolidation, renewal, etc. for the half year ended March 31, 2018. Kindly take the same on your records.10-04-2018
Compliance Certificate For The Period Ended March 31, 2018
Pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we hereby confirm that the activities in relation to both physical and electronic share transfer facility for the period from October 1, 2017 to March 31, 2018 are maintained with the Company's Registrar and Share Transfer Agent, Link Intime India Private Limited, having its registered office at C - 101, 247 Park, LBS Marg, Vikhroli West, Mumbai...10-04-2018
Novartis bets big on gene therapy with $8.7 billion AveXis deal
This is Novartis's second notable gene therapy deal this year09-04-2018
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement of Notice of Board Meeting to be held on May 10, 201804-04-2018
Board to consider Final Dividend
Novartis India Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled be held on May 10, 2018 to consider, inter alia, the audited financial results for the fourth quarter and year ended March 31, 2018 and recommendation of final dividend on equity shares, if any, for the said year. Further, pursuant to the Code of conduct to regulate, monitor and report share trading by Insiders, the trading window for...29-03-2018
Meeting Of The Board Of Directors To Be Held On May 10, 2018
Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the meeting of the Board of Directors of the Company is scheduled be held on Thursday, May 10, 2018 to consider, inter alia, the audited financial results for the fourth quarter and year ended March 31, 2018 and recommendation of final dividend on equity shares, if any, for the said year....29-03-2018
GSK Set To Buy Novartis Stake In JV For $13 Billion
Completion of the buyout by GSK of Novartis 36.5% stake in the joint venture is currently expected to occur during the summer of 2018.28-03-2018
Novartis India Vice Chairman and Managing Director Jawed Zia resigns
Novartis India today said its Vice Chairman and Managing Director Jawed Zia has decided to step down from the post. "Jawed Zia, Vice Chairman & Managing Director, Novartis India Limited has informed the Board of Directors of his decision to step down from the office of Vice Chairman and Managing Director at the close of business hours on May 31, 2018," the company said in a BSE filing. The board, the filing said, has requested the nomination and remuneration committee to identify and recommend a suitable successor for the role of Vice Chairman and Managing Director of the company. In India, the pharmaceutical business of Novartis India Ltd is focused on bone and pain, calcium portfolio, gynaecology and neuroscience and the generic business is focused on gynaecology, anti-TB and anti-infectives.17-03-2018
Announcement under Regulation 30 (LODR)-Resignation of Managing Director
Pursuant to Regulation 30 of SEBI (Listing Disclosure Requirements) Regulations, 2015, we wish to inform you that Jawed Zia, Vice Chairman & Managing Director, Novartis India Limited has informed the Board of Directors of his decision to step down from the office of Vice Chairman and Managing Director at the close of business hours on May 31, 2018....17-03-2018